Open Access

Combined effects of Lenvatinib and iodine‑131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress

  • Authors:
    • Guoyu Wang
    • Juhua Zhuang
    • Jing Ni
    • Ying Ye
    • Saifei He
    • Wei Xia
  • View Affiliations

  • Published online on: August 23, 2018     https://doi.org/10.3892/etm.2018.6652
  • Pages: 3325-3332
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Nasopharyngeal carcinoma (NPC) is a type of malignant tumor characterized by high invasiveness, metastatic potential and worldwide incidence among patients with head and neck cancer. It has previously been demonstrated that Lenvatinib (LEB) is an efficient anti‑cancer agent by multi‑targeting of tyrosine kinase inhibitors. Iodine‑131 (I‑131) therapy has been accepted for the treatment of thyroid cancer and other carcinomas. In the present study, the combined effects of LEB and I‑131 were investigated on NPC and the potential signal pathway mediated by LEB and I‑131 on NPC cells was explored. Inhibitory effects of LEB and I‑131 for NPC cells growth were investigated via MTT assay. Migration and invasion of NPC cells was studied by aggression assays following incubation of LEB and I‑131. Apoptosis of NPC cells and tissues were analyzed via flow cytometry and TUNEL assay, respectively. Apoptosis‑related gene expression levels in NPC cells following treatment with LEB and I‑131 were determined by western blotting. Endoplasmic reticulum (ER) stress in NPC cells were analyzed in NPC cells and tumor tissues. Immunohistochemistry was used to analyze the efficacy of LEB and I‑131 in NPC‑tumor bearing mice. The results demonstrated that combined treatment of LEB and I‑131 significantly inhibited growth, apoptosis, migration and invasion of NPC cells compared with single agent therapy. Apoptosis‑related gene expression levels of caspase‑3 and caspase‑9 were upregulated by LEB and I‑131, whereas B call lymphoma‑2, and P53 were downregulated in NPC cells and tumor tissues. In addition, signal mechanism analysis demonstrated that combined treatment of LEB and I‑131 promoted expression levels of activating transcription factor 6, inositol‑requiring protein 1 (IER1), protein kinase RNA‑like endoplasmic reticulum kinase (RERK), and C/EBP homologous protein in NPC cells. Furthermore, combined treatment of LEB and I‑131 markedly inhibited in vivo growth of NPC and further prolonged survival of experimental mice compared with single agent and control groups. Immunohistochemistry indicated that c‑jun N‑terminal kinase and Caspase‑3 were increased in NPS tumor tissues in xenograft models treated with LEB and I‑131. Apoptotic bodies were also increased in tumors treated by LEB and I‑131. In conclusion, these findings indicate that combined treatment of LEB and I‑131 may inhibit NPC growth and aggression through upregulation of ER stress, suggesting combined treatment of LEB and I‑131 may be a potential therapeutic schedule for the treatment of NPC.
View Figures
View References

Related Articles

Journal Cover

October-2018
Volume 16 Issue 4

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang G, Zhuang J, Ni J, Ye Y, He S and Xia W: Combined effects of Lenvatinib and iodine‑131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress. Exp Ther Med 16: 3325-3332, 2018
APA
Wang, G., Zhuang, J., Ni, J., Ye, Y., He, S., & Xia, W. (2018). Combined effects of Lenvatinib and iodine‑131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress. Experimental and Therapeutic Medicine, 16, 3325-3332. https://doi.org/10.3892/etm.2018.6652
MLA
Wang, G., Zhuang, J., Ni, J., Ye, Y., He, S., Xia, W."Combined effects of Lenvatinib and iodine‑131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress". Experimental and Therapeutic Medicine 16.4 (2018): 3325-3332.
Chicago
Wang, G., Zhuang, J., Ni, J., Ye, Y., He, S., Xia, W."Combined effects of Lenvatinib and iodine‑131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress". Experimental and Therapeutic Medicine 16, no. 4 (2018): 3325-3332. https://doi.org/10.3892/etm.2018.6652